| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Finance &Accounting
1 company
Tessmer James F is a VP, Finance &Accounting at LEXICON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 1 buy and 5 sells.
Estimated insider holdings value: $172K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2021 | LXRX Lexicon Pharmaceuticals, Inc. | VP, Finance &Accounting | Sale+OE | 22,912 | $6.92 | $158,439.72 | -13.8% | -30.3% | -71.6% | |
| Aug 2, 2019 | LXRX Lexicon Pharmaceuticals, Inc. | VP, Finance &Accounting | Buy | 10,000 | $1.14 | $11,400.00 | +30.0% | - | - | |
| Jun 8, 2018 | LXRX Lexicon Pharmaceuticals, Inc. | VP, Finance &Accounting | Sale+OE | 10,000 | $12.91 | $129,076.00 | -28.1% | - | - | |
| Jun 6, 2016 | LXRX Lexicon Pharmaceuticals, Inc. | VP, Finance &Accounting | Sale+OE | 1,500 | $15.00 | $22,500.00 | -8.6% | - | - | |
| May 23, 2016 | LXRX Lexicon Pharmaceuticals, Inc. | VP, Finance &Accounting | Sale+OE | 6,000 | $13.00 | $78,000.00 | -27.3% | - | - |